Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice

Neurobiology of Aging

Volumn 35, Issue 3, 2014, Pages 556-564

  Lillehaug, Sveinung ^a   Syverstad, Gry H ^a   Nilsson, Lars N G ^b,c   Bjaalie, Jan G ^a   Leergaard, Trygve B ^a   Torp, Reidun ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Amyloidosis; Digital brain atlas; Disease model; Immunohistochemistry; Power analysis

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN;

ADULT; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; SEX DIFFERENCE; TECTUM; THALAMUS;

ALZHEIMER'S DISEASE; AMYLOIDOSIS; DIGITAL BRAIN ATLAS; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; POWER ANALYSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTROCHEMICAL, SCANNING; PLAQUE, AMYLOID;

EID: 84889581315     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.09.013     Document Type: Article

References (44)

1. Andra K., Abramowski D., Duke M., Probst A., Wiederhold K.H., Burki K., Goedert M., Sommer B., Staufenbiel M. Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol. Aging 1996, 17:183-190.
2. Bjaalie J.G., Leergaard T.B., Lillehaug S., Odeh F., Moene I.A., Kjode J.O., Darin D. Database and tools for analysis of topographic organization and map transformations in major projection systems of the brain. Neuroscience 2005, 136:681-695. 10.1016/j.neuroscience.2005.06.036.
3. Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403. 10.1016/S0140-6736(06)69113-7.
4. Boy J., Leergaard T.B., Schmidt T., Odeh F., Bichelmeier U., Nuber S., Holzmann C., Wree A., Prusiner S.B., Bujard H., Riess O., Bjaalie J.G. Expression mapping of tetracycline-responsive prion protein promoter: digital atlasing for generating cell-specific disease models. Neuroimage 2006, 33:449-462. 10.1016/j.neuroimage.2006.05.055.
5. Brown R.E. Behavioural phenotyping of transgenic mice. Can. J. Exp. Psychol. 2007, 61:328-344. 10.1037/cjep2007033.
6. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., Sheline Y.I., Klunk W.E., Mathis C.A., Morris J.C., Mintun M.A. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J.Neurosci. 2005, 25:7709-7717. 10.1523/JNEUROSCI.2177-05.2005.
7. Callahan M.J., Lipinski W.J., Bian F., Durham R.A., Pack A., Walker L.C. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am. J. Pathol. 2001, 158:1173-1177.
8. Christenson D.Z., Bayer T.A., Wirths O. Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Abeta peptides in mouse models of Alzheimer's disease. Brain Res. 2009, 1301:116-125. 10.1016/j.brainres.2009.09.014.
9. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992, 360:672-674. 10.1038/360672a0.
10. Duyckaerts C., Delatour B., Potier M.C. Classification and basic pathology of Alzheimer disease. Acta. Neuropathol. 2009, 118:5-36. 10.1007/s00401-009-0532-1.
11. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., Mcconlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wasdsworth S., Wolozin B., Zhau J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995, 373:523-527. 10.1038/373523a0.
12. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 2000, 156:15-20.
13. Holtzman D.M., Morris J.C., Goate A.M. Alzheimer's disease: the challenge of the second century. Sci. Transl. Med. 2011, 3:77sr1. 10.1126/scitranslmed.3002369.
14. Hoogland P.V., Welker E., Van der Loos H. Organization of the projections from barrel cortex to thalamus in mice studied with Phaseolus vulgaris-leucoagglutinin and HRP. Exp. Brain Res. 1987, 68:73-87.
15. Jarrett J.T., Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993, 73:1055-1058.
16. Jucker M. The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat. Med. 2010, 16:1210-1214. 10.1038/nm.2224.
17. Lazarov O., Lee M., Peterson D.A., Sisodia S.S. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J.Neurosci. 2002, 22:9785-9793.
18. Lord A., Englund H., Soderberg L., Tucker S., Clausen F., Hillered L., Gordon M., Morgan D., Lannfelt L., Pettersson F.E., Nilsson L.N. Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice. FEBS J. 2009, 276:995-1006. 10.1111/j.1742-4658.2008.06836.x.
19. Lord A., Kalimo H., Eckman C., Zhang X.Q., Lannfelt L., Nilsson L.N. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Neurobiol. Aging 2006, 27:67-77. 10.1016/j.neurobiolaging.2004.12.007.
20. Lord A., Philipson O., Klingstedt T., Westermark G., Hammarstrom P., Nilsson K.P., Nilsson L.N. Observations in APP bitransgenic mice suggest that diffuse and compact plaques form via independent processes in Alzheimer's disease. Am. J. Pathol. 2011, 178:2286-2298. 10.1016/j.ajpath.2011.01.052.
21. Magnusson K.S.D., Syvänen S., Svedberg M.M., Philipson O., Söderberg L., Tegerstedt L., Holmquist M., Gellerfors P., Tolmachev V., Antoni G., Lannfelt L., Hall H., Nilsson L.N.G. Specific uptake of an amyloid-β protofibril-binding antibody-tracer in AβPP transgenic mouse brain. J.Alzheimers Dis. 2013, 37:29-40.
22. Mastrangelo M.A., Bowers W.J. Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice. BMC Neurosci. 2008, 9:81. 10.1186/1471-2202-9-81.
23. Moene I.A., Subramaniam S., Darin D., Leergaard T.B., Bjaalie J.G. Toward a workbench for rodent brain image data: systems architecture and design. Neuroinformatics 2007, 5:35-58.
24. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. Apathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1992, 1:345-347. 10.1038/ng0892-345.
25. Näslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000, 283:1571-1577. 10.1001/jama.283.12.1571.
26. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C., Stenh C., Luthman J., Teplow D.B., Younkin S.G., Naslund J., Lannfelt L. The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 2001, 4:887-893. 10.1038/nn0901-887.
27. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
28. Odeh F., Leergaard T.B., Boy J., Schmidt T., Riess O., Bjaalie J.G. Atlas of transgenic Tet-Off Ca2+/calmodulin-dependent protein kinase II and prion protein promoter activity in the mouse brain. Neuroimage 2011, 54:2603-2611. 10.1016/j.neuroimage.2010.11.032.
29. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., Finkbeiner S., Noebels J.L., Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711. 10.1016/j.neuron.2007.07.025.
30. Philipson O., Hammarstrom P., Nilsson K.P., Portelius E., Olofsson T., Ingelsson M., Hyman B.T., Blennow K., Lannfelt L., Kalimo H., Nilsson L.N. Ahighly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice. Neurobiol. Aging 2009, 30:1393-1405. 10.1016/j.neurobiolaging.2007.11.022.
31. Philipson O., Lannfelt L., Nilsson L.N. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice. FEBS Lett. 2009, 583:3021-3026. 10.1016/j.febslet.2009.08.009.
32. Philipson O., Lord A., Gumucio A., O'Callaghan P., Lannfelt L., Nilsson L.N. Animal models of amyloid-beta-related pathologies in Alzheimer's disease. FEBS J. 2010, 277:1389-1409. 10.1111/j.1742-4658.2010.07564.x.
33. Philipson O., Lord A., Lalowski M., Soliymani R., Baumann M., Thyberg J., Bogdanovic N., Olofsson T., Tjernberg L.O., Ingelsson M., Lannfelt L., Kalimo H., Nilsson L.N. The Arctic amyloid-beta precursor protein (AbetaPP) mutation results in distinct plaques and accumulation of N- and C-truncated Abeta. Neurobiol. Aging 2012, 33. 1010.e1-13. 10.1016/j.neurobiolaging.2011.10.022.
34. Rönnbäck A., Zhu S., Dillner K., Aoki M., Lilius L., Naslund J., Winblad B., Graff C. Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model. Neurobiol. Aging 2011, 32:280-292. 10.1016/j.neurobiolaging.2009.02.021.
35. Schellenberg G.D., Montine T.J. The genetics and neuropathology of Alzheimer's disease. Acta Neuropathol. 2012, 124:305-323. 10.1007/s00401-012-0996-2.
36. Sedgewick J. Scientific Imaging with Photoshop: Methods, Measurement, and Output 2008, Peachpit Press, California, ISBN-10: 0321514335.
37. Sheng J.G., Price D.L., Koliatsos V.E. Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis. J.Neurosci. 2002, 22:9794-9799.
38. Sherman S.M., Guillery R.W. Functional organization of thalamocortical relays. J.Neurophysiol. 1996, 76:1367-1395.
39. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Twoamyloid precursor protein transgenic mouse models with Alzheimerdisease-like pathology. Proc. Natl. Acad. Sci. U.S.A 1997, 94:13287-13292.
40. Takumi Y., Ramirez-Leon V., Laake P., Rinvik E., Ottersen O.P. Different modes of expression of AMPA and NMDA receptors in hippocampal synapses. Nat. Neurosci. 1999, 2:618-624. 10.1038/10172.
41. Vidal M., Morris R., Grosveld F., Spanopoulou E. Tissue-specific control elements of the Thy-1 gene. EMBO J. 1990, 9(3):833-840.
42. Welker E., Hoogland P.V., Van der Loos H. Organization of feedback and feedforward projections of the barrel cortex: a PHA-L study in the mouse. Exp. Brain Res. 1988, 73:411-435.
43. Weller R.O., Djuanda E., Yow H.Y., Carare R.O. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol. 2009, 117:1-14. 10.1007/s00401-008-0457-0.
44. Yang J., Lunde L.K., Nuntagij P., Oguchi T., Camassa L.M., Nilsson L.N., Lannfelt L., Xu Y., Amiry-Moghaddam M., Ottersen O.P., Torp R. Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease. J.Alzheimers Dis. 2011, 27:711-722. 10.3233/JAD-2011-110725.